ProfileGDS4132 / 209279_s_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 43% 45% 40% 34% 45% 45% 41% 49% 35% 39% 31% 36% 37% 36% 23% 34% 28% 39% 35% 38% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101113.99843
GSM201543Muscle PCOS pioglitazone 121111.34945
GSM201544Muscle PCOS pioglitazone 161104.35140
GSM201545Muscle PCOS pioglitazone 20194.381734
GSM201829Muscle PCOS pioglitazone 231127.70545
GSM201830Muscle PCOS pioglitazon 251123.02645
GSM201831Muscle PCOS pioglitazone 271107.72241
GSM201832Muscle PCOS pioglitazone 31128.66949
GSM201833Muscle PCOS pioglitazone 4183.641835
GSM201834Muscle PCOS pioglitazone 8197.760839
GSM201835Muscle PCOS after pioglitazone 10264.096731
GSM201836Muscle PCOS after pioglitazone 12279.62936
GSM201837Muscle PCOS after pioglitazone 16279.670737
GSM201838Muscle PCOS after pioglitazone 20281.193136
GSM201839Muscle PCOS after pioglitazone 23248.336723
GSM201840Muscle PCOS after pioglitazone 25281.749734
GSM201841Muscle PCOS after pioglitazone 27254.065928
GSM201842Muscle PCOS after pioglitazone 3282.213139
GSM201843Muscle PCOS after pioglitazone 4284.776435
GSM201844Muscle PCOS after pioglitazone 8291.622938